{"id":"albuterol-sulphate","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Tremor"},{"rate":"5-10","effect":"Nervousness or anxiety"},{"rate":"5-10","effect":"Headache"},{"rate":"2-5","effect":"Palpitations"},{"rate":"2-5","effect":"Muscle cramps"},{"rate":"2-5","effect":"Tachycardia"}]},"_chembl":{"chemblId":"CHEMBL1441059","moleculeType":"Small molecule","molecularWeight":"576.71"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Albuterol activates beta-2 adrenergic receptors on bronchial smooth muscle, triggering a cascade that increases intracellular cAMP and leads to smooth muscle relaxation. This results in rapid airway dilation and improved airflow, providing symptomatic relief of bronchoconstriction. It is commonly used as a rescue medication for acute bronchospasm and as a maintenance therapy in obstructive airway diseases.","oneSentence":"Albuterol sulfate is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:19.326Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute bronchospasm and reversible obstructive airway disease"},{"name":"Asthma (acute and maintenance therapy)"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT06052267","phase":"PHASE3","title":"A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations","status":"RECRUITING","sponsor":"Teva Branded Pharmaceutical Products R&D LLC","startDate":"2023-08-30","conditions":"Asthma","enrollment":2700},{"nctId":"NCT06664619","phase":"PHASE3","title":"A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma","status":"RECRUITING","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2024-12-12","conditions":"Asthma","enrollment":724},{"nctId":"NCT03890666","phase":"PHASE4","title":"A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2020-10-26","conditions":"Asthma","enrollment":333},{"nctId":"NCT06471257","phase":"PHASE3","title":"A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-06-17","conditions":"Asthma","enrollment":790},{"nctId":"NCT06307665","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-05-20","conditions":"Asthma","enrollment":440},{"nctId":"NCT01931696","phase":"NA","title":"Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma","status":"COMPLETED","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2013-08","conditions":"Asthma","enrollment":200},{"nctId":"NCT05555290","phase":"PHASE3","title":"PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-09-28","conditions":"Asthma","enrollment":190},{"nctId":"NCT06785272","phase":"PHASE3","title":"Magnesium Trial in Acute Asthma in Emergency Department","status":"RECRUITING","sponsor":"Suzanne Schuh","startDate":"2025-10-08","conditions":"Asthma","enrollment":192},{"nctId":"NCT03952286","phase":"PHASE4","title":"ED-Initiated School-based Asthma Medication Supervision","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2019-08-01","conditions":"Asthma, Asthma in Children","enrollment":13},{"nctId":"NCT06644924","phase":"PHASE2","title":"A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-02-10","conditions":"Asthma","enrollment":118},{"nctId":"NCT06245551","phase":"PHASE3","title":"A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-12-22","conditions":"Asthma, Exercise-Induced","enrollment":64},{"nctId":"NCT06514157","phase":"PHASE1","title":"Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-08-19","conditions":"Healthy Volunteer","enrollment":14},{"nctId":"NCT06290102","phase":"PHASE1","title":"Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2024-05-16","conditions":"Asthma","enrollment":30},{"nctId":"NCT05505734","phase":"PHASE3","title":"A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2022-09-02","conditions":"Asthma","enrollment":2516},{"nctId":"NCT06154304","phase":"PHASE3","title":"BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma","status":"COMPLETED","sponsor":"Cipla Ltd.","startDate":"2023-12-06","conditions":"Bronchial Asthma","enrollment":120},{"nctId":"NCT05099107","phase":"NA","title":"Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2021-10-25","conditions":"Congenital Myopathy, Neuromuscular Diseases, Musculoskeletal Diseases","enrollment":18},{"nctId":"NCT05035862","phase":"PHASE1","title":"Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma","status":"TERMINATED","sponsor":"Emory University","startDate":"2022-03-16","conditions":"Asthma","enrollment":1},{"nctId":"NCT06946264","phase":"PHASE3","title":"Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features","status":"RECRUITING","sponsor":"Nemours Children's Clinic","startDate":"2022-07-08","conditions":"Bronchiolitis, Bronchodilator Agents","enrollment":400},{"nctId":"NCT05987371","phase":"PHASE2","title":"A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-08-23","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":75},{"nctId":"NCT04912596","phase":"NA","title":"Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma","status":"RECRUITING","sponsor":"Intech Biopharm Ltd.","startDate":"2022-08-15","conditions":"Mild Asthma","enrollment":148},{"nctId":"NCT06825013","phase":"PHASE4","title":"Bronchodilators and Lung Mechanics During Exercise in COPD","status":"RECRUITING","sponsor":"Dr. J. Alberto Neder","startDate":"2024-11-10","conditions":"COPD","enrollment":25},{"nctId":"NCT04159519","phase":"PHASE4","title":"A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-07-27","conditions":"Asthma, Severe Eosinophilic Asthma","enrollment":170},{"nctId":"NCT06618105","phase":"PHASE3","title":"Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd","status":"NOT_YET_RECRUITING","sponsor":"Macleods Pharmaceuticals Ltd","startDate":"2024-10-15","conditions":"Mild Asthma","enrollment":144},{"nctId":"NCT06482294","phase":"PHASE2","title":"CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Università degli Studi di Ferrara","startDate":"2024-06-18","conditions":"Asthma","enrollment":80},{"nctId":"NCT00649987","phase":"PHASE1","title":"Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-09","conditions":"Healthy","enrollment":21},{"nctId":"NCT04803734","phase":"NA","title":"Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Intech Biopharm Ltd.","startDate":"2021-03-19","conditions":"Healthy","enrollment":60},{"nctId":"NCT05300087","phase":"NA","title":"Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Intech Biopharm Ltd.","startDate":"2022-02-24","conditions":"Healthy","enrollment":60},{"nctId":"NCT06271408","phase":"PHASE1","title":"Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging","status":"UNKNOWN","sponsor":"Polarean, Inc.","startDate":"2024-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":6},{"nctId":"NCT05241288","phase":"NA","title":"Digihaler in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-03-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":54},{"nctId":"NCT03157102","phase":"NA","title":"High Flow Nasal Cannula in Children With Status Asthmaticus","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2018-08-08","conditions":"Status Asthmaticus","enrollment":272},{"nctId":"NCT03333395","phase":"PHASE4","title":"Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2017-02-01","conditions":"Mechanically Ventilated Patients","enrollment":60},{"nctId":"NCT00665600","phase":"PHASE3","title":"Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2002-02","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":257},{"nctId":"NCT03847896","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2019-03-20","conditions":"Asthma","enrollment":1001},{"nctId":"NCT04929626","phase":"PHASE1","title":"Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2022-01-01","conditions":"Status Asthmaticus","enrollment":126},{"nctId":"NCT03219736","phase":"NA","title":"NiPPV in the Treatment of Acute Asthma Exacerbations","status":"WITHDRAWN","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2017-06-01","conditions":"Bronchial Asthma, Status Asthmaticus","enrollment":""},{"nctId":"NCT03662711","phase":"PHASE4","title":"Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease","status":"TERMINATED","sponsor":"Università degli Studi di Ferrara","startDate":"2018-11-11","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":843},{"nctId":"NCT03842839","phase":"NA","title":"Effect of Tiotropium on Airway Remodeling in Patients With Early Stage COPD Accessed by Optical Coherence Tomography","status":"UNKNOWN","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2018-10-01","conditions":"Airway Remodeling","enrollment":100},{"nctId":"NCT03769090","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2018-12-13","conditions":"Asthma","enrollment":3132},{"nctId":"NCT05292976","phase":"PHASE3","title":"Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation","status":"WITHDRAWN","sponsor":"Aurobindo Pharma Ltd","startDate":"2022-04","conditions":"Bronchial Asthma","enrollment":""},{"nctId":"NCT04848662","phase":"PHASE1","title":"To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2021-05-06","conditions":"Asthma","enrollment":12},{"nctId":"NCT00308685","phase":"PHASE3","title":"Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2006-06-10","conditions":"Asthma","enrollment":95},{"nctId":"NCT04681079","phase":"","title":"Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19","status":"COMPLETED","sponsor":"Theravance Biopharma","startDate":"2021-05-04","conditions":"COVID-19","enrollment":14},{"nctId":"NCT01899144","phase":"PHASE2","title":"Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-07","conditions":"Asthma","enrollment":61},{"nctId":"NCT04234464","phase":"PHASE3","title":"A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2020-01-15","conditions":"Exercise Induced Bronchospasm","enrollment":60},{"nctId":"NCT05152355","phase":"PHASE4","title":"Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients","status":"COMPLETED","sponsor":"Intech Biopharm Ltd.","startDate":"2019-04-22","conditions":"Asthma","enrollment":270},{"nctId":"NCT00577655","phase":"PHASE3","title":"Albuterol HFA MDI in Pediatric Participants With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2007-08","conditions":"Asthma","enrollment":103},{"nctId":"NCT03256695","phase":"PHASE3","title":"Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2017-09-28","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":405},{"nctId":"NCT02969408","phase":"PHASE3","title":"A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2017-02-13","conditions":"Asthma","enrollment":397},{"nctId":"NCT03468790","phase":"PHASE3","title":"Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.","status":"COMPLETED","sponsor":"Shanghai Biomabs Pharmaceutical Co., Ltd.","startDate":"2018-05-09","conditions":"Asthma, Allergic","enrollment":393},{"nctId":"NCT04668027","phase":"NA","title":"Impulse Oscillation to Evaluate Diagnostic Efficacy in Patients With Chronic Airway Disease","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2020-01-01","conditions":"Chronic Airway Disease","enrollment":172},{"nctId":"NCT04584034","phase":"PHASE4","title":"Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial","status":"WITHDRAWN","sponsor":"UMC Utrecht","startDate":"2021-09","conditions":"Wheezing","enrollment":""},{"nctId":"NCT03586544","phase":"PHASE4","title":"Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity","status":"TERMINATED","sponsor":"University of Nevada, Las Vegas","startDate":"2018-09-18","conditions":"Asthma in Children, Obesity, Childhood, Exercise Induced Bronchospasm","enrollment":34},{"nctId":"NCT02966184","phase":"PHASE4","title":"Comparison of Albuterol for Status Asthmaticus","status":"TERMINATED","sponsor":"Norton Healthcare","startDate":"2018-09-10","conditions":"Status Asthmaticus","enrollment":8},{"nctId":"NCT02566902","phase":"NA","title":"Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma","status":"COMPLETED","sponsor":"Seton Healthcare Family","startDate":"2015-10","conditions":"Asthma","enrollment":118},{"nctId":"NCT04207840","phase":"PHASE4","title":"Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2019-12-09","conditions":"Pharmacokinetics, Epinephrine, Albuterol","enrollment":28},{"nctId":"NCT03098680","phase":"PHASE1","title":"A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems","status":"TERMINATED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2017-04-24","conditions":"Drug-Related Side Effects and Adverse Reactions, Cardiovascular System Disease","enrollment":18},{"nctId":"NCT03528577","phase":"PHASE3","title":"A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2018-09-22","conditions":"Asthma","enrollment":128},{"nctId":"NCT02584257","phase":"PHASE3","title":"Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma","status":"COMPLETED","sponsor":"Lupin, Inc.","startDate":"2016-04","conditions":"Mild Persistent Asthma","enrollment":217},{"nctId":"NCT00522444","phase":"PHASE3","title":"Nebulized Magnesium Sulfate in Pediatric Asthma","status":"WITHDRAWN","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2007-09","conditions":"Asthma","enrollment":""},{"nctId":"NCT01429415","phase":"PHASE2","title":"Magnesium Nebulization Utilization in Management of Pediatric Asthma","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2011-09-26","conditions":"Acute Asthma","enrollment":818},{"nctId":"NCT03934333","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-05-16","conditions":"Relative Bioavailability","enrollment":11},{"nctId":"NCT02766673","phase":"NA","title":"Aerosolized Albuterol Use in Severe BPD","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2016-08","conditions":"Severe Bronchopulmonary Dysplasia","enrollment":24},{"nctId":"NCT02624505","phase":"PHASE3","title":"Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma","status":"COMPLETED","sponsor":"Cipla Ltd.","startDate":"2015-12","conditions":"Bronchial Asthma","enrollment":110},{"nctId":"NCT03371459","phase":"PHASE2","title":"Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-12-29","conditions":"Asthma","enrollment":46},{"nctId":"NCT02447250","phase":"PHASE4","title":"Preterm Infant Inhaled Albuterol Dosing","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2013-10-24","conditions":"Bronchopulmonary Dysplasia, Very Low Birth Weight","enrollment":14},{"nctId":"NCT03271905","phase":"NA","title":"Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilator","status":"UNKNOWN","sponsor":"Universidade Federal do Rio Grande do Norte","startDate":"2017-04-10","conditions":"COPD, Asthma","enrollment":10},{"nctId":"NCT03772223","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-01-21","conditions":"Healthy Volunteers","enrollment":91},{"nctId":"NCT01515995","phase":"PHASE4","title":"Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2012-01","conditions":"Asthma","enrollment":50},{"nctId":"NCT03071731","phase":"NA","title":"Glittre ADL-test: Responsiveness to Acute Bronchodilation in Chronic Obstructive Pulmonary Disease (COPD)","status":"UNKNOWN","sponsor":"Laval University","startDate":"2017-04-13","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":34},{"nctId":"NCT00394329","phase":"PHASE3","title":"(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2006-11","conditions":"Asthma","enrollment":288},{"nctId":"NCT01984086","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-10-21","conditions":"Asthma","enrollment":60},{"nctId":"NCT03549897","phase":"PHASE3","title":"Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base","status":"UNKNOWN","sponsor":"Amneal Ireland Limited","startDate":"2018-03-16","conditions":"Asthma","enrollment":100},{"nctId":"NCT03296579","phase":"NA","title":"Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2018-06","conditions":"Asthma Acute, Asthma in Children","enrollment":100},{"nctId":"NCT03091504","phase":"NA","title":"Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2017-09-04","conditions":"High Flow Nasal Cannula","enrollment":42},{"nctId":"NCT03480997","phase":"PHASE1","title":"Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD","status":"COMPLETED","sponsor":"Pneuma Respiratory, Inc","startDate":"2016-12-27","conditions":"COPD","enrollment":46},{"nctId":"NCT00310401","phase":"PHASE2","title":"The Effect of Nebulized Albuterol on Donor Oxygenation","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2007-04","conditions":"Brain Death, Organ Donor, Pulmonary Edema","enrollment":506},{"nctId":"NCT01252758","phase":"PHASE2","title":"Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma","status":"WITHDRAWN","sponsor":"Acerus Pharmaceuticals Corporation","startDate":"2012-11","conditions":"Asthma","enrollment":""},{"nctId":"NCT02566252","phase":"PHASE1","title":"Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)","status":"COMPLETED","sponsor":"Pulmotect, Inc.","startDate":"2015-07","conditions":"Healthy","enrollment":16},{"nctId":"NCT03169504","phase":"PHASE3","title":"Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2017-05","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":150},{"nctId":"NCT00861926","phase":"PHASE3","title":"Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2009-03","conditions":"Asthma","enrollment":2079},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT03059017","phase":"PHASE1","title":"In Vivo Investigation of Novel Nano-vesicles of Salbutamol Sulphate","status":"COMPLETED","sponsor":"British University In Egypt","startDate":"2017-02-05","conditions":"Drug Effect, Pulmonary Disease","enrollment":20},{"nctId":"NCT00434993","phase":"PHASE2, PHASE3","title":"Drug Study of Albuterol to Treat Acute Lung Injury","status":"TERMINATED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2007-08","conditions":"Respiratory Distress Syndrome, Adult","enrollment":282},{"nctId":"NCT02764307","phase":"NA","title":"Aerosol Delivery in Different Types of Nebulizers","status":"COMPLETED","sponsor":"Chang Gung University","startDate":"2015-10","conditions":"Asthma","enrollment":10},{"nctId":"NCT02987036","phase":"NA","title":"Delivery of Beta Agonists is Technique Sensitive (DOBATS)Mechanics","status":"COMPLETED","sponsor":"Southeast University, China","startDate":"2015-01","conditions":"Respiratory Failure","enrollment":30},{"nctId":"NCT00144846","phase":"PHASE3","title":"Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-09","conditions":"Asthma","enrollment":80},{"nctId":"NCT02405598","phase":"PHASE4","title":"Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2013-10","conditions":"Pompe Disease","enrollment":14},{"nctId":"NCT01987219","phase":"PHASE3","title":"The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2013-03","conditions":"Familial Dysautonomia","enrollment":15},{"nctId":"NCT02584738","phase":"PHASE4","title":"Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation","status":"UNKNOWN","sponsor":"Hospital General Naval de Alta Especialidad - Escuela Medico Naval","startDate":"2015-09","conditions":"Asthma","enrollment":152},{"nctId":"NCT01791972","phase":"PHASE3","title":"Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-03","conditions":"Exercise-Induced Bronchoconstriction (EIB)","enrollment":38},{"nctId":"NCT02182856","phase":"PHASE4","title":"Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-02","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":33},{"nctId":"NCT02182700","phase":"PHASE3","title":"Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"1998-07","conditions":"Asthma","enrollment":47},{"nctId":"NCT02182713","phase":"PHASE4","title":"Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-05","conditions":"Asthma","enrollment":30},{"nctId":"NCT02173678","phase":"PHASE1","title":"Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1999-10","conditions":"Healthy","enrollment":12},{"nctId":"NCT00634517","phase":"PHASE3","title":"4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma","status":"TERMINATED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2008-03","conditions":"Asthma","enrollment":48},{"nctId":"NCT00634829","phase":"PHASE3","title":"Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction","status":"TERMINATED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2008-02","conditions":"Asthma, Bronchospasm","enrollment":24},{"nctId":"NCT01799109","phase":"NA","title":"Lung Function of Asthmatic Children by Nebulized MgSO4","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2011-11","conditions":"Asthma","enrollment":90},{"nctId":"NCT01856959","phase":"NA","title":"Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2011-11","conditions":"Asthma","enrollment":330},{"nctId":"NCT00393367","phase":"PHASE4","title":"Budesonide Inhalation Suspension for Acute Asthma in Children","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2006-12","conditions":"Asthma, Acute Asthma, Reactive Airway Exacerbation","enrollment":179}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["(Proventil ®)"],"phase":"phase_3","status":"active","brandName":"Albuterol-sulphate","genericName":"Albuterol-sulphate","companyName":"NYU Langone Health","companyId":"nyu-langone-health","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Albuterol sulfate is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation. Used for Acute bronchospasm and reversible obstructive airway disease, Asthma (acute and maintenance therapy), Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}